trial

On Track Chile For First Episode Psychosis

NCTId NCT04247711
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 300 (estimated)
Sponsored by University of Chile
Primary completion 2024-03-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
300 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2021-03-25
Primary completion
2024-03-30
Eligibility
ALL · 15 Years · 35 Years

Interventions & indications

Drugs
OTCHUsual FEP Services

Sponsors

University of ChileLead Sponsor
Universidad de O'HigginsCollaborator
Columbia UniversityCollaborator
Washington University School of MedicineCollaborator
New York UniversityCollaborator
Research Foundation for Mental Hygiene, Inc.Collaborator
New York State Psychiatric Institute, Washington Heights Community ServiceCollaborator

Investigators

1
Ruben Alvarado, MD PhDPrincipal Investigator

Sites

1 total
Santiago, Chile

Facts & assertions

4 sourced
Enrollment
300
Phase
NA
Primary Completion Date
2024-03-30
Status
UNKNOWN
relationships
The graph out of here
drug
OTCH
drug
Usual FEP Services
drug
lead_sponsor
University of Chile
company
collaborator
Universidad de O'Higgins
company
Columbia University
company
indication
Psychosis
indication
Psychotic Disorders
indication
investigator
Ruben Alvarado, MD PhD
person